Cargando…
Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment
Autores principales: | Marshall, Bess A., Green, Rebecca P., Wambach, Jennifer, White, Neil H., Remedi, Maria S., Nichols, Colin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876698/ https://www.ncbi.nlm.nih.gov/pubmed/25715421 http://dx.doi.org/10.2337/dc14-2124 |
Ejemplares similares
-
Acute Sulfonylurea Therapy at Disease Onset Can Cause Permanent Remission of K(ATP)-Induced Diabetes
por: Remedi, Maria Sara, et al.
Publicado: (2011) -
Chronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-Cells
por: Remedi, Maria Sara, et al.
Publicado: (2008) -
Role of Noninsulin Therapies Alone or in Combination in Chromosome 6q24-Related Transient Neonatal Diabetes: Sulfonylurea Improves but Does Not Always Normalize Insulin Secretion
por: Carmody, David, et al.
Publicado: (2015) -
Type 1 Diabetes in Children With Genetic Risk May Be Predicted Very Early With a Blood miRNA
por: Suomi, Tomi, et al.
Publicado: (2022) -
Management of Diabetic Ketoacidosis in Severe Insulin Resistance
por: Robinson, Cemre, et al.
Publicado: (2016)